Warning letter
Beauty & Health International Inc.: warning letter of Feb 5, 2016
FDA warning letter UCM502275 · Los Angeles District Office
Key facts
| Reference number | UCM502275 |
|---|---|
| Company | Beauty & Health International Inc. |
| Subject | CGMP/Dietary Supplement/Adulterated/Misbranded |
| Issue date | Feb 5, 2016 |
| Posted date | Feb 5, 2016 |
| Issuing office | Los Angeles District Office |
| Product type | Food/Cosmetics |
| CFR sections cited | 111.65, 111.75, 111.103, 111.210, 101.4(h)(1), 101.9(b), 111.70(a), 111.70(b), 111.70(b)(2), 111.70(c)(1), 111.70(e), 101.15(c) and 11 more |
| Country | 3 |
| Inspection city | Santa Ana |
| Inspection ZIP | 92704 |
| Inspection start date | Aug 25, 2015 |
| Letter on fda.gov | web.archive.org |
At a glance
- 10–99 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: